Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.

Suppr

超能文献

作者信息

Pitts A F, Samuelson S D, Meller W H, Bissette G, Nemeroff C B, Kathol R G

机构信息

Department of Psychiatry, University of Iowa Hospitals and Clinics, Iowa City 52242, USA.

出版信息

Biol Psychiatry. 1995 Sep 1;38(5):330-5. doi: 10.1016/0006-3223(95)00229-A.

DOI:10.1016/0006-3223(95)00229-A

PMID:7495928

Abstract

摘要

相似文献

Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.

Biol Psychiatry. 1995 Sep 1;38(5):330-5. doi: 10.1016/0006-3223(95)00229-A.

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.

Am J Psychiatry. 1993 Apr;150(4):656-7. doi: 10.1176/ajp.150.4.656.

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.

Depress Anxiety. 1998;8(2):71-9.

Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients.

Psychoneuroendocrinology. 2007 Jun;32(5):464-9. doi: 10.1016/j.psyneuen.2007.02.010. Epub 2007 Apr 17.

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

Biol Psychiatry. 1997 Aug 1;42(3):165-74. doi: 10.1016/S0006-3223(96)00312-5.

Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?

Biol Psychiatry. 2007 Jul 1;62(1):47-54. doi: 10.1016/j.biopsych.2006.07.039. Epub 2006 Nov 21.

Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.

Psychoneuroendocrinology. 2004 Oct;29(9):1101-8. doi: 10.1016/j.psyneuen.2003.11.004.

[Monitoring the neurobiological and psychopathological course in therapy of depression. Trimipramine, sleep deprivation and light].

Bibl Psychiatr. 1994(166):1-138.

Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.

Psychoneuroendocrinology. 2008 Feb;33(2):152-61. doi: 10.1016/j.psyneuen.2007.10.011.

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse.

Eur Neuropsychopharmacol. 1992 Jun;2(2):107-13. doi: 10.1016/0924-977x(92)90019-5.

引用本文的文献

The neurobiological impact of oxytocin in mental health disorders: a comprehensive review.

Ann Med Surg (Lond). 2025 Feb 7;87(3):1479-1486. doi: 10.1097/MS9.0000000000003015. eCollection 2025 Mar.

A Stress Protein-Based Suicide Prediction Score and Relationship to Reported Early-Life Adversity and Recent Life Stress.

Int J Neuropsychopharmacol. 2023 Jul 31;26(7):501-512. doi: 10.1093/ijnp/pyad025.

Oxytocin: Narrative Expert Review of Current Perspectives on the Relationship with Other Neurotransmitters and the Impact on the Main Psychiatric Disorders.

Medicina (Kaunas). 2022 Jul 11;58(7):923. doi: 10.3390/medicina58070923.

Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases.

J Clin Med. 2022 Feb 9;11(4):908. doi: 10.3390/jcm11040908.

Anti-Anxiety Effect of (-)-Syringaresnol-4-O-β-d-apiofuranosyl-(1→2)-β-d-glucopyranoside from Albizzia julibrissin Durazz (Leguminosae).

Molecules. 2017 Aug 11;22(8):1331. doi: 10.3390/molecules22081331.

Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment.

Pharmaceuticals (Basel). 2010 Mar 16;3(3):702-724. doi: 10.3390/ph3030702.

Evaluation of an antenatal acupuncture intervention as an adjunct therapy for antenatal depression (AcuAnteDep): study protocol for a pragmatic randomised controlled trial.

Trials. 2016 Feb 17;17:93. doi: 10.1186/s13063-016-1204-9.

From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders.

Front Neurosci. 2016 Jan 12;9:497. doi: 10.3389/fnins.2015.00497. eCollection 2015.

The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.

Harv Rev Psychiatry. 2013 Sep-Oct;21(5):219-47. doi: 10.1097/HRP.0b013e3182a75b7d.

Oxytocin and postpartum depression: delivering on what's known and what's not.

Brain Res. 2014 Sep 11;1580:219-32. doi: 10.1016/j.brainres.2013.11.009. Epub 2013 Nov 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验